FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2738712721> ?p ?o ?g. }

• W2738712721 endingPage "1453" @default.
• W2738712721 startingPage "1446" @default.
• W2738712721 abstract "To evaluate the pharmacodynamics, pharmacokinetics and safety of single subcutaneous (s.c.) injection of ascending doses of RG7697, a dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 agonist, in healthy subjects.A total of 51 healthy volunteers were enrolled in this double-blind, placebo-controlled study investigating RG7697 doses ranging from 0.03 to 5 mg. Adverse events (AEs) were monitored and drug concentrations, fasting glycaemic variables, vital signs, ECG, antibody formation and routine laboratory variables were assessed. A meal tolerance test (MTT) was performed at the same time on day -1 (baseline) and day 1.RG7697 was generally well tolerated in healthy participants after s.c. injections up to 3.6 mg. Tolerability was limited by gastrointestinal AEs (nausea and vomiting) at the highest dose. There was a small dose-dependent increase in heart rate. No episodes of hypoglycaemia occurred. RG7697 concentrations peaked at 2 to 4 hours post-dose with a half-life of 19 to 25 hours. During MTT, RG7697 at doses ≥1.8 mg, reduced glucose maximum plasma concentration (Cmax ; -46%) without affecting overall glucose area under the curve (AUC). Its effect on insulin was more pronounced, with reductions in both Cmax (-64%) and AUC (-51%). Pharmacodynamic variables were well correlated to RG7697 average plasma concentration during MTT, with IC50 (average concentration required for 50% reduction) values of 49 and 24.5 ng/mL for glucose and insulin, respectively.Single s.c. injections of RG7697 up to 3.6 mg were generally well tolerated. Evidence of glycaemic effect and pharmacokinetic profiles consistent with once-daily dosing render this drug candidate suitable to be further tested in multiple-dose clinical trials in patients with type 2 diabetes." @default.
• W2738712721 created "2017-07-31" @default.
• W2738712721 creator A5002428093 @default.
• W2738712721 creator A5020001100 @default.
• W2738712721 creator A5027169785 @default.
• W2738712721 creator A5055639851 @default.
• W2738712721 creator A5071517746 @default.
• W2738712721 date "2017-07-25" @default.
• W2738712721 modified "2023-09-29" @default.
• W2738712721 title "Pharmacodynamics, pharmacokinetics, safety and tolerability of the novel dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 agonist RG7697 after single subcutaneous administration in healthy subjects" @default.
• W2738712721 cites W1898466139 @default.
• W2738712721 cites W1994989824 @default.
• W2738712721 cites W2004507897 @default.
• W2738712721 cites W2007910256 @default.
• W2738712721 cites W2013293490 @default.
• W2738712721 cites W2029355071 @default.
• W2738712721 cites W2041551639 @default.
• W2738712721 cites W2064437324 @default.
• W2738712721 cites W2067710447 @default.
• W2738712721 cites W2070361040 @default.
• W2738712721 cites W2074511950 @default.
• W2738712721 cites W2084948079 @default.
• W2738712721 cites W2085456136 @default.
• W2738712721 cites W2114104256 @default.
• W2738712721 cites W2139923324 @default.
• W2738712721 cites W2143612861 @default.
• W2738712721 cites W2147817624 @default.
• W2738712721 cites W2149717292 @default.
• W2738712721 cites W2196084315 @default.
• W2738712721 doi "https://doi.org/10.1111/dom.13025" @default.
• W2738712721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28741871" @default.
• W2738712721 hasPublicationYear "2017" @default.
• W2738712721 type Work @default.
• W2738712721 sameAs 2738712721 @default.
• W2738712721 citedByCount "36" @default.
• W2738712721 countsByYear W27387127212017 @default.
• W2738712721 countsByYear W27387127212018 @default.
• W2738712721 countsByYear W27387127212019 @default.
• W2738712721 countsByYear W27387127212020 @default.
• W2738712721 countsByYear W27387127212021 @default.
• W2738712721 countsByYear W27387127212022 @default.
• W2738712721 countsByYear W27387127212023 @default.
• W2738712721 crossrefType "journal-article" @default.
• W2738712721 hasAuthorship W2738712721A5002428093 @default.
• W2738712721 hasAuthorship W2738712721A5020001100 @default.
• W2738712721 hasAuthorship W2738712721A5027169785 @default.
• W2738712721 hasAuthorship W2738712721A5055639851 @default.
• W2738712721 hasAuthorship W2738712721A5071517746 @default.
• W2738712721 hasConcept C111113717 @default.
• W2738712721 hasConcept C112705442 @default.
• W2738712721 hasConcept C126322002 @default.
• W2738712721 hasConcept C134018914 @default.
• W2738712721 hasConcept C142724271 @default.
• W2738712721 hasConcept C197934379 @default.
• W2738712721 hasConcept C204787440 @default.
• W2738712721 hasConcept C22979827 @default.
• W2738712721 hasConcept C27081682 @default.
• W2738712721 hasConcept C2778375690 @default.
• W2738712721 hasConcept C2779306644 @default.
• W2738712721 hasConcept C2780580376 @default.
• W2738712721 hasConcept C71924100 @default.
• W2738712721 hasConcept C76318530 @default.
• W2738712721 hasConcept C87813604 @default.
• W2738712721 hasConcept C98274493 @default.
• W2738712721 hasConceptScore W2738712721C111113717 @default.
• W2738712721 hasConceptScore W2738712721C112705442 @default.
• W2738712721 hasConceptScore W2738712721C126322002 @default.
• W2738712721 hasConceptScore W2738712721C134018914 @default.
• W2738712721 hasConceptScore W2738712721C142724271 @default.
• W2738712721 hasConceptScore W2738712721C197934379 @default.
• W2738712721 hasConceptScore W2738712721C204787440 @default.
• W2738712721 hasConceptScore W2738712721C22979827 @default.
• W2738712721 hasConceptScore W2738712721C27081682 @default.
• W2738712721 hasConceptScore W2738712721C2778375690 @default.
• W2738712721 hasConceptScore W2738712721C2779306644 @default.
• W2738712721 hasConceptScore W2738712721C2780580376 @default.
• W2738712721 hasConceptScore W2738712721C71924100 @default.
• W2738712721 hasConceptScore W2738712721C76318530 @default.
• W2738712721 hasConceptScore W2738712721C87813604 @default.
• W2738712721 hasConceptScore W2738712721C98274493 @default.
• W2738712721 hasFunder F4320307779 @default.
• W2738712721 hasIssue "10" @default.
• W2738712721 hasLocation W27387127211 @default.
• W2738712721 hasLocation W27387127212 @default.
• W2738712721 hasOpenAccess W2738712721 @default.
• W2738712721 hasPrimaryLocation W27387127211 @default.
• W2738712721 hasRelatedWork W1541103017 @default.
• W2738712721 hasRelatedWork W1822154343 @default.
• W2738712721 hasRelatedWork W1977160484 @default.
• W2738712721 hasRelatedWork W2091460425 @default.
• W2738712721 hasRelatedWork W2112620969 @default.
• W2738712721 hasRelatedWork W2250173847 @default.
• W2738712721 hasRelatedWork W2611950068 @default.
• W2738712721 hasRelatedWork W2626992247 @default.
• W2738712721 hasRelatedWork W3146022116 @default.
• W2738712721 hasRelatedWork W3207313530 @default.
• W2738712721 hasVolume "19" @default.
• W2738712721 isParatext "false" @default.

• next